Updating the mild encephalitis hypothesis of schizophrenia

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 42, Issue , 2013, Pages 71-91

  Bechter, K ^a  

^a UNIVERSITY OF ULM   (Germany)

Author keywords

Autoimmunity; Gene environment immune interactions; Low level neuroinflammation; Mild encephalitis hypothesis; Psychoneuroimmunology; Schizophrenia

Indexed keywords

NEUROTRANSMITTER;

ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; BLOOD BRAIN BARRIER; BORNA DISEASE VIRUS; CEREBROSPINAL FLUID FLOW; DIAGNOSTIC TEST; ENCEPHALITIS; ENVIRONMENTAL FACTOR; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; IMMUNE RESPONSE; MULTIPLE SCLEROSIS; NERVE CELL DIFFERENTIATION; NERVOUS SYSTEM INFLAMMATION; NEUROIMAGING; PARANEOPLASTIC NEUROPATHY; PATHOPHYSIOLOGY; PHASE TRANSITION; RISK FACTOR; SCHIZOPHRENIA; SYNAPTIC TRANSMISSION; VIRUS INFECTION;

ANIMALS; CENTRAL NERVOUS SYSTEM INFECTIONS; ENCEPHALITIS; HUMANS; IMMUNITY, CELLULAR; RISK FACTORS; SCHIZOPHRENIA;

EID: 84873523614     PISSN: 02785846     EISSN: 18784216     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2012.06.019     Document Type: Article

References (308)

1. Adamson L.A., Fowler L.J., Clare-Salzler M.J., Hobbs J.A. Parvovirus B19 infection in Hashimoto's thyroiditis, papillary thyroid carcinoma, and anaplastic thyroid carcinoma. Thyroid 2011, 21:411-417.
2. Agnati L.F., Bjelke B., Fuxe K. Volume versus wiring transmission in the brain: a new theoretical frame for neuropsychopharmacology. Med Res Rev 1995, 15:33-45.
3. Agnati L.F., Guidolin D., Guescini M., Genedani S., Fuxe K. Understanding wiring and volume transmission. Brain Res Rev 2010, 64:137-159.
4. Allen J.E., Maizels R.M. Diversity and dialogue in immunity to helminths. Nat Rev Immunol 2011, 11:375-388.
5. Andreasen N. Neuroimaging of schizophrenia: commentary. Understanding neuropsychiatric disorders - insights from neuroimaging 2011, 88. Cambridge University Press, New York. M.E. Shenton, B.I. Turetsky (Eds.).
6. Andreasen N.C., Nopoulos P., Magnotta V., Pierson R., Ziebell S., Ho B.C. Progressive brain change in schizophrenia: a prospective longitudinal study of first-episode schizophrenia. Biol Psychiatry 2011, 70(7):672-679.
7. Andreone N., Tansella M., Cerini R., Versace A., Rambaldelli G., Perlini C., et al. Cortical white-matter microstructure in schizophrenia. Diffusion imaging study. Br J Psychiatry 2007, 191:113-119.
8. Anthony D.C., Couch Y., Losey P., Evans M.C. The systemic response to brain injury and disease. Brain Behav Immun 2012, 26:534-540.
9. Arbuckle J.H., Medveczky M.M., Luka J., Hadley S.H., Luegmayr A., Ablashi D., et al. The latent human herpesvirus-6A genome specifically integrates in telomeres of human chromosomes in vivo and in vitro. Proc Natl Acad Sci U S A 2010, 107:5563-5568.
10. Arias I., Sorlozano A., Villegas E., Luna J.D., McKenney K., Cervilla J., et al. Infectious agents associated with schizophrenia: a meta-analysis. Schizophr Res 2012, 136(1-3):128-136.
11. Arnold I.C., Dehzad N., Reuter S., Martin H., Becher B., Taube C., et al. Helicobacter pylori infection prevents allergic asthma in mouse models through the induction of regulatory T cells. J Clin Invest 2011, 121:3088-3093.
12. Auerbach B.D., Osterweil E.K., Bear M.F. Mutations causing syndromic autism define an axis of synaptic pathophysiology. Nature 2011, 480:63-68.
13. Bachmann M.F., Jennings G.T. Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns. Nat Rev Immunol 2010, 10:787-796.
14. Bahn S., Schwarz E. Serum-based biomarkers for psychiatric disorders. Nervenarzt 2011, 82:1395-1403.
15. Bar K.J., Greiner W., Jochum T., Friedrich M., Wagner G., Sauer H. The influence of major depression and its treatment on heart rate variability and pupillary light reflex parameters. J Affect Disord 2004, 82:245-252.
16. Bar K.J., Berger S., Metzner M., Boettger M.K., Schulz S., Ramachandraiah C.T., et al. Autonomic dysfunction in unaffected first-degree relatives of patients suffering from schizophrenia. Schizophr Bull 2010, 36:1050-1058.
17. Bartholomaus I., Kawakami N., et al. Effector T cell interactions with meningeal vascular structures in nascent autoimmune CNS lesions. Nature 2009, 462(7269):94-98.
18. Bayer T.A., Falkai P., Maier W. Genetic and non-genetic vulnerability factors in schizophrenia: the basis of the "two hit hypothesis". J Psychiatr Res 1999, 33:543-548.
19. Bechmann I., Galea I., Perry V.H. What is the blood-brain barrier (not)?. Trends Immunol 2007, 28:5-11.
20. Bechter K., Bogerts B. Inflammatory and neuroimmunological aspects in psychiatric disorders. Highlights of the 9th Psychoimmunology Expert Meeting: Neuropsychoimmunology of Psychoses. Immune and Inflammatory Aspects of Psychoses. In Vivo 2007, 21:917-923.
21. Bechter K. Borna Disease Virus. Mögliche Ursache neurologischer und psychiatrischer Störungen des Menschen. Monographien aus dem Gesamtgebiete Psychiatrie 1998, Steinkopff, Darmstadt. H. Hippius, W. Janzarik, C. Müller (Eds.).
22. Bechter K. Mild encephalitis underlying psychiatric disorder - a reconsideration and hypothesis exemplified on Borna disease. Neurol Psychiatry Brain Res 2001, 9:55-70.
23. Bechter K. The peripheral cerebrospinal fluid outflow pathway - physiology and pathophysiology of CSF recirculation: a review and hypothesis. Neurol Psychiatry Brain Res 2011, 17:51-66.
24. Bechter, K., in press. Diagnosis of infectious or inflammatory psychosyndromes. Open J Neurol.
25. Bechter K., Hodgkiss A. Research strategies in 'slow' infections in psychiatry. Hist Psychiatry 1995, 6:503-511.
26. Bechter K., Herzog S., Behr W., Schuttler R. Investigations of cerebrospinal fluid in Borna disease virus seropositive psychiatric patients. Eur Psychiatry 1995, 10:250-258.
27. Bechter K., Herzog S., Schreiner V., Wollinsky K.H., Schüttler R. Cerebrospinal fluid filtration in a case of schizophrenia related to 'subclinical' Borna disease virus encephalitis. Psychiatry, psychoneuroimmunology and viruses. Key top brain res 1999, 19-35. Springer, Wien. N. Müller (Ed.).
28. Bechter K., Herzog S., Schreiner V., Brinkmeier H., Aulkemeyer P., Weber F., et al. Borna disease virus-related therapy-resistant depression improved after cerebrospinal fluid filtration. J Psychiatr Res 2000, 34:393-396.
29. Bechter K., Bindl A., Horn M., Schreiner V. Therapieresistente Depression mit Fatigue. Fall einer vermutlichen streptokokkenassoziierten Autoimmunkrankheit. Nervenarzt 2007, 78(338):340-341.
30. Bechter K., Reiber H., Herzog S., Fuchs D., Tumani H., Maxeiner H.G. Cerebrospinal fluid analysis in affective and schizophrenic spectrum disorders: identification of subgroups with immune responses and blood-CSF barrier dysfunction. J Psychiatr Res 2010, 44:321-330.
31. Bechter K., Wittek R., Seitz K., Antoniadis G. Personality disorders improved after arachnoid cyst neurosurgery, then rediagnosed as 'minor' organic personality disorders. Psychiatry Res 2010, 184:196-200.
32. Belarbi K., Arellano C., Ferguson R., Jopson T., Rosi S. Chronic neuroinflammation impacts the recruitment of adult-born neurons into behaviorally relevant hippocampal networks. Brain Behav Immun 2011, 26:18-23.
33. Belyi V.A., Levine A.J., Skalka A.M. Unexpected inheritance: multiple integrations of ancient bornavirus and ebolavirus/marburgvirus sequences in vertebrate genomes. PLoS Pathog 2010, 6:e1001030.
34. Benedetti F., Radaelli D., Poletti S., Falini A., Cavallaro R., Dallaspezia S., et al. Emotional reactivity in chronic schizophrenia: structural and functional brain correlates and the influence of adverse childhood experiences. Psychol Med 2011, 41:509-519.
35. Benros M., Nielsen P., Nordentoft M., Eaton W.W., Dalton S.O., Mortensen P.B. Autoimmune diseases and severe infections as risk factors for schizophrenia - a 30-year population-based register study. Am J Psychiatry 2011, 168:1303-1310.
36. Bentivoglio M., Mariotti R., Bertini G. Neuroinflammation and brain infections: historical context and current perspectives. Brain Res Rev 2011, 66:152-173.
37. Bertsias G.K., Boumpas D.T. Pathogenesis, diagnosis and management of neuropsychiatric SLE manifestations. Nat Rev Rheumatol 2010, 6:358-367.
38. Bien C.G., Urbach H., Schramm J., Soeder B.M., Becker A.J., Voltz R., et al. Limbic encephalitis as a precipitating event in adult-onset temporal lobe epilepsy. Neurology 2007, 69:1236-1244.
39. Billich C., Sauder C., Frank R., Herzog S., Bechter K., Takahashi K., et al. High-avidity human serum antibodies recognizing linear epitopes of Borna disease virus proteins. Biol Psychiatry 2002, 51:979-987.
40. Bode L., Ludwig H. Borna disease virus infection, a human mental-health risk. Clin Microbiol Rev 2003, 16:534-545.
41. Bondy B. Genetics in psychiatry: are the promises met?. World J Biol Psychiatry 2011, 12:81-88.
42. Bostrom I., Callander M., Kurtzke J.F., Landtblom A.M. High prevalence of multiple sclerosis in the Swedish county of Varmland. Mult Scler 2009, 15:1253-1262.
43. Bozzi Y., Casarosa S., Caleo M. Epilepsy as a neurodevelopmental disorder. Front Psychiatry 2012, 3. Article 19.
44. Braak H., Del Tredici K. Invited article: nervous system pathology in sporadic Parkinson disease. Neurology 2008, 70:1916-1925.
45. Brennand K.J., Simone A., Jou J., Gelboin-Burkhart C., Tran N., Sangar S., et al. Modelling schizophrenia using human induced pluripotent stem cells. Nature 2011, 473:221-225.
46. Bromet E.J., Kotov R., Fochtmann L.J., Carlson G.A., Tanenberg-Karant M., Ruggero C., et al. Diagnostic shifts during the decade following first admission for psychosis. Am J Psychiatry 2011, 168:1186-1194.
47. Brown A.S. Further evidence of infectious insults in the pathogenesis and pathophysiology of schizophrenia. Am J Psychiatry 2011, 168:764-766.
48. Brown A.S. The environment and susceptibility to schizophrenia. Prog Neurobiol 2011, 93:23-58.
49. Brown A.S. Exposure to prenatal infection and risk of schizophrenia. Front Psychiatry 2011, 2:63.
50. Brown A.S., McGrath J.J. The prevention of schizophrenia. Schizophr Bull 2011, 37:257-261.
51. Brown A.S., Cohen P., Harkavy-Friedman J., Babulas V., Malaspina D., Gorman J.M., et al. A.E. Bennett Research Award. Prenatal rubella, premorbid abnormalities, and adult schizophrenia. Biol Psychiatry 2001, 49:473-486.
52. Brown A.S., Begg M.D., Gravenstein S., Schaefer C.A., Wyatt R.J., Bresnahan M., et al. Serologic evidence of prenatal influenza in the etiology of schizophrenia. Arch Gen Psychiatry 2004, 61:774-780.
53. Bucy D.S., Brown M.S., Bielefeldt-Ohmann H., Thompson J., Bachand A.M., Morges M., et al. Early detection of neuropathophysiology using diffusion-weighted magnetic resonance imaging in asymptomatic cats with feline immunodeficiency viral infection. J Neurovirol 2011, 17:341-352.
54. Buka S.L., Tsuang M.T., Torrey E.F., Klebanoff M.A., Bernstein D., Yolken R.H. Maternal infections and subsequent psychosis among offspring. Arch Gen Psychiatry 2001, 58:1032-1037.
55. Bunge S.A. The developing human brain: a frontiers research topic. Front Hum Neurosci 2012, 6:1.
56. Bustillo J.R., Rowland L.M., Mullins P., Jung R., Chen H., Qualls C., et al. 1H-MRS at 4Tesla in minimally treated early schizophrenia. Mol Psychiatry 2010, 15:629-636.
57. Cadwell K., Patel K.K., Maloney N.S., Liu T.C., Ng A.C., Storer C.E., et al. Virus-plus-susceptibility gene interaction determines Crohn's disease gene Atg16L1 phenotypes in intestine. Cell 2010, 141:1135-1145.
58. Calabrese M., Agosta F., Rinaldi F., Mattisi I., Grossi P., Favaretto A., et al. Cortical lesions and atrophy associated with cognitive impairment in relapsing-remitting multiple sclerosis. Arch Neurol 2009, 66:1144-1150.
59. Carbone K.M. Borna disease virus and its role in neurobehavioral disease 2002, ASM Press, Washington, DC.
60. Carlsson M.L., Carlsson A., Nilsson M. Schizophrenia: from dopamine to glutamate and back. Curr Med Chem 2004, 11:267-277.
61. Caspi A., Hariri A.R., Holmes A., Uher R., Moffitt T.E. Genetic sensitivity to the environment: the case of the serotonin transporter gene and its implications for studying complex diseases and traits. Am J Psychiatry 2010, 167:509-527.
62. Chawarska K., Campbell D., Chen L., Shic F., Klin A., Chang J. Early generalized overgrowth in boys with autism. Arch Gen Psychiatry 2011, 68:1021-1031.
63. Chen G.Y., Nunez G. Sterile inflammation: sensing and reacting to damage. Nat Rev Immunol 2010, 10:826-837.
64. Cherner M., Cysique L., Heaton R.K., Marcotte T.D., Ellis R.J., Masliah E., et al. Neuropathologic confirmation of definitional criteria for human immunodeficiency virus-associated neurocognitive disorders. J Neurovirol 2007, 13:23-28.
65. Chevalier G., Suberbielle E., Monnet C., Duplan V., Martin-Blondel G., Farrugia F., et al. Neurons are MHC class I-dependent targets for CD8 T cells upon neurotropic viral infection. PLoS Pathog 2011, 7:e1002393.
66. Clarke M.C., Tanskanen A., Huttunen M., Leon D.A., Murray R.M., Jones P.B., et al. Increased risk of schizophrenia from additive interaction between infant motor developmental delay and obstetric complications: evidence from a population-based longitudinal study. Am J Psychiatry 2011, 168:1295-1302.
67. Clemente R., Sisman E., Aza-Blanc P., de la Torre J.C. Identification of host factors involved in Borna disease virus cell entry through a small interfering RNA functional genetic screen. J Virol 2010, 84:3562-3575.
68. Coban O., Bahar S., Akman-Demir G., Tasci B., Yurdakul S., Yazici H., et al. Masked assessment of MRI findings: is it possible to differentiate neuro-Behcet's disease from other central nervous system diseases? [corrected]. Neuroradiology 1999, 41:255-260.
69. Cohen I.R. Real and artificial immune systems: computing the state of the body. Nat Rev Immunol 2007, 7:569-574.
70. Cserr H.F., Knopf P.M. Cervical lymphatics, the blood-brain barrier and the immunoreactivity of the brain: a new view. Immunol Today 1992, 13:507-512.
71. Daito T., Fujino K., Watanabe Y., Ikuta K., Tomonaga K. Analysis of intracellular distribution of borna disease virus glycoprotein fused with fluorescent markers in living cells. J Vet Med Sci 2011, 73:1243-1247.
72. Daito T., Fujino K., Honda T., Matsumoto Y., Watanabe Y., Tomonaga K. A novel Borna disease virus vector system that stably expresses foreign proteins from an intercistronic noncoding region. J Virol 2011.
73. Dalman C., Allebeck P., Gunnell D., Harrison G., Kristensson K., Lewis G., et al. Infections in the CNS during childhood and the risk of subsequent psychotic illness: a cohort study of more than one million Swedish subjects. Am J Psychiatry 2008, 165:59-65.
74. Dalmau J. Anti-NMDAR and other synaptic mechanisms of autoimmune encephalitis. Abstracts of the 8th International Congress on Autoimmunity 2012, www.kenes.com/autoimmunity.
75. Dalmau J., Lancaster E., Martinez-Hernandez E., Rosenfeld M.R., Balice-Gordon R. Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. Lancet Neurol 2011, 10:63-74.
76. Dantzer R., Capuron L., Irwin M.R., Miller A.H., Ollat H., Perry V.H., et al. Identification and treatment of symptoms associated with inflammation in medically ill patients. Psychoneuroendocrinology 2008, 33:18-29.
77. Davis K.L., Stewart D.G., Friedman J.I., Buchsbaum M., Harvey P.D., Hof P.R., et al. White matter changes in schizophrenia: evidence for myelin-related dysfunction. Arch Gen Psychiatry 2003, 60:443-456.
78. de Castro-Manglano P., Mechelli A., Soutullo C., Gimenez-Amaya J., Ortuno F., McGuire P. Longitudinal changes in brain structure following the first episode of psychosis. Psychiatry Res 2011, 191:166-173.
79. De Hert M., Wampers M., Jendricko T., Franic T., Vidovic D., De Vriendt N., et al. Effects of cannabis use on age at onset in schizophrenia and bipolar disorder. Schizophr Res 2011, 126:270-276.
80. De Nayer A.R., Myant N., Sindic C.J. A subacute behavioral disorder in a female adolescent. Autoimmune anti-N-methyl-d-aspartate receptor encephalitis associated with ovarian teratoma. Biol Psychiatry 2009, 66:e13-e14.
81. Dean K., Fearon P., Morgan K., Hutchinson G., Orr K., Chitnis X., et al. Grey matter correlates of minor physical anomalies in the AeSOP first-episode psychosis study. Br J Psychiatry 2006, 189:221-228.
82. Derecki N.C., Cardani A.N., Yang C.H., Quinnies K.M., Crihfield A., Lynch K.R., et al. Regulation of learning and memory by meningeal immunity: a key role for IL-4. J Exp Med 2010, 207:1067-1080.
83. Dickerson F., Boronow J., Stallings C., Origoni A., Yolken R. Toxoplasma gondii in individuals with schizophrenia: association with clinical and demographic factors and with mortality. Schizophr Bull 2007, 33:737-740.
84. Dickerson F., Stallings C., Origoni A., Vaughan C., Khushalani S., Yolken R. Additive effects of elevated C-reactive protein and exposure to herpes simplex virus type 1 on cognitive impairment in individuals with schizophrenia. Schizophr Res 2012, 134:83-88.
85. Dietz D., Vogel M., Rubin S., Moran T., Carbone K., Pletnikov M. Developmental alterations in serotoninergic neurotransmission in Borna disease virus (BDV)-infected rats: a multidisciplinary analysis. J Neurovirol 2004, 10:267-277.
86. Doorduin J., de Vries E.F., Willemsen A.T., de Groot J.C., Dierckx R.A., Klein H.C. Neuroinflammation in schizophrenia-related psychosis: a PET study. J Nucl Med 2009, 50:1801-1807.
87. Drexhage R.C., Knijff E.M., Padmos R.C., Heul-Nieuwenhuijzen L., Beumer W., Versnel M.A., et al. The mononuclear phagocyte system and its cytokine inflammatory networks in schizophrenia and bipolar disorder. Expert Rev Neurother 2010, 10:59-76.
88. Drexhage R.C., van der Heul-Nieuwenhuijsen L., Padmos R.C., van Beveren N., Cohen D., Versnel M.A., et al. Inflammatory gene expression in monocytes of patients with schizophrenia: overlap and difference with bipolar disorder. A study in naturalistically treated patients. Int J Neuropsychopharmacol 2010, 13:1369-1381.
89. Dunne D.W., Cooke A. A worm's eye view of the immune system: consequences for evolution of human autoimmune disease. Nat Rev Immunol 2005, 5:420-426.
90. Durrwald R., Kolodziejek J., Muluneh A., Herzog S., Nowotny N. Epidemiological pattern of classical Borna disease and regional genetic clustering of Borna disease viruses point towards the existence of to-date unknown endemic reservoir host populations. Microbes Infect 2006, 8:917-929.
91. Durrwald R., Kolodziejek J., Herzog S., Nowotny N. Meta-analysis of putative human bornavirus sequences fails to provide evidence implicating Borna disease virus in mental illness. Rev Med Virol 2007, 17:181-203.
92. Dworkin J., Shah I.M. Exit from dormancy in microbial organisms. Nat Rev Microbiol 2010, 8:890-896.
93. Eack S.M., Hogarty G.E., Cho R.Y., Prasad K.M., Greenwald D.P., Hogarty S.S., et al. Neuroprotective effects of cognitive enhancement therapy against gray matter loss in early schizophrenia: results from a 2-year randomized controlled trial. Arch Gen Psychiatry 2010, 67:674-682.
94. Ehrenreich H., Bartels C., Sargin D., Stawicki S., Krampe H. Recombinant human erythropoietin in the treatment of human brain disease: focus on cognition. J Ren Nutr 2008, 18:146-153.
95. Ekdahl C.T., Kokaia Z., Lindvall O. Brain inflammation and adult neurogenesis: the dual role of microglia. Neuroscience 2009, 158:1021-1029.
96. Engelhardt B., Sorokin L. The blood-brain and the blood-cerebrospinal fluid barriers: function and dysfunction. Semin Immunopathol 2009, 31:497-511.
97. Fallon B.A., Lipkin R.B., Corbera K.M., Yu S., Nobler M.S., Keilp J.G., et al. Regional cerebral blood flow and metabolic rate in persistent Lyme encephalopathy. Arch Gen Psychiatry 2009, 66:554-563.
98. Fatemi S.H., Folsom T.D. The neurodevelopmental hypothesis of schizophrenia, revisited. Schizophr Bull 2009, 35:528-548.
99. Fatemi S.H., Folsom T.D., Rooney R.J., Mori S., Kornfield T.E., Reutiman T.J., et al. The viral theory of schizophrenia revisited: abnormal placental gene expression and structural changes with lack of evidence for H1N1 viral presence in placentae of infected mice or brains of exposed offspring. Neuropharmacology 2012, 62:1290-1298.
100. Fathman C.G., Soares L., Chan S.M., Utz P.J. An array of possibilities for the study of autoimmunity. Nature 2005, 435:605-611.
101. Feschotte C. Virology: Bornavirus enters the genome. Nature 2010, 463:39-40.
102. Feschotte C., Gilbert C. Endogenous viruses: insights into viral evolution and impact on host biology. Nat Rev Genet 2012, 13:283-296.
103. Flyckt L., Borg J., Borg K., Ansved T., Edman G., Bjerkenstedt L., et al. Muscle biopsy, macro EMG, and clinical characteristics in patients with schizophrenia. Biol Psychiatry 2000, 47:991-999.
104. Foxe J.J., Yeap S., Snyder A.C., Kelly S.P., Thakore J.H., Molholm S. The N1 auditory evoked potential component as an endophenotype for schizophrenia: high-density electrical mapping in clinically unaffected first-degree relatives, first-episode, and chronic schizophrenia patients. Eur Arch Psychiatry Clin Neurosci 2011, 261:331-339.
105. Fusar-Poli P., Borgwardt S., Crescini A., Deste G., Kempton M.J., Lawrie S., et al. Neuroanatomy of vulnerability to psychosis: a voxel-based meta-analysis. Neurosci Biobehav Rev 2011, 35:1175-1185.
106. Fusar-Poli P., Crossley N., Woolley J., Carletti F., Perez-Iglesias R., Broome M., et al. Gray matter alterations related to P300 abnormalities in subjects at high risk for psychosis: longitudinal MRI-EEG study. Neuroimage 2011, 55:320-328.
107. Fusar-Poli P., Howes O.D., Allen P., Broome M., Valli I., Asselin M.C., et al. Abnormal prefrontal activation directly related to pre-synaptic striatal dopamine dysfunction in people at clinical high risk for psychosis. Mol Psychiatry 2011, 16:67-75.
108. Fuxe K., Dahlstrom A.B., Jonsson G., Marcellino D., Guescini M., Dam M., et al. The discovery of central monoamine neurons gave volume transmission to the wired brain. Prog Neurobiol 2010, 90:82-100.
109. Garver D.L., Tamas R.L., Holcomb J.A. Elevated interleukin-6 in the cerebrospinal fluid of a previously delineated schizophrenia subtype. Neuropsychopharmacology 2003, 28:1515-1520.
110. Garver D.L., Holcomb J.A., Christensen J.D. Compromised myelin integrity during psychosis with repair during remission in drug-responding schizophrenia. Int J Neuropsychopharmacol 2008, 11:49-61.
111. Gattaz W.F., Abrahao A.L., Foccacia R. Childhood meningitis, brain maturation and the risk of psychosis. Eur Arch Psychiatry Clin Neurosci 2004, 254:23-26.
112. Gawryluk J.W., Wang J.F., Andreazza A.C., Shao L., Young L.T. Decreased levels of glutathione, the major brain antioxidant, in post-mortem prefrontal cortex from patients with psychiatric disorders. Int J Neuropsychopharmacol 2011, 14:123-130.
113. Glaser C.A., Honarmand S., Anderson L.J., Schnurr D.P., Forghani B., Cossen C.K., et al. Beyond viruses: clinical profiles and etiologies associated with encephalitis. Clin Infect Dis 2006, 43:1565-1577.
114. Gleeson M., Bishop N.C., Stensel D.J., Lindley M.R., Mastana S.S., Nimmo M.A. The anti-inflammatory effects of exercise: mechanisms and implications for the prevention and treatment of disease. Nat Rev Immunol 2011, 11:607-615.
115. Glezer I., Simard A.R., Rivest S. Neuroprotective role of the innate immune system by microglia. Neuroscience 2007, 147:867-883.
116. Goldmann J., Kwidzinski E., et al. T cells traffic from brain to cervical lymph nodes via the cribroid plate and the nasal mucosa. J Leukoc Biol 2006, 80(4):797-801.
117. Goldmann J., Kwidzinski E., Brandt C., Mahlo J., Richter D., Bechmann I. T cells traffic from brain to cervical lymph nodes via the cribroid plate and the nasal mucosa. J Leukoc Biol 2006, 80:797-801.
118. Gorczynski L.Y., Gorczynski C.P., Terzioglu T., Gorczynski R. Pre- and postnatal influences of neurohormonal triggering and behaviour on the immune system of offspring. Adv Neuroimmune Biol 2011, 1:39-51.
119. Grace P.M., Rolan P.E., Hutchinson M.R. Peripheral immune contributions to the maintenance of central glial activation underlying neuropathic pain. Brain Behav Immun 2011, 25(7):1322-1332.
120. Graham A.L., Hayward A.D., Watt K.A., Pilkington J.G., Pemberton J.M., Nussey D.H. Fitness correlates of heritable variation in antibody responsiveness in a wild mammal. Science 2010, 330:662-665.
121. Grassiot B., Desgranges B., Eustache F., Defer G. Quantification and clinical relevance of brain atrophy in multiple sclerosis: a review. J Neurol 2009, 256:1397-1412.
122. Graus F., Boronat A., Xifro X., Boix M., Svigelj V., Garcia A., et al. The expanding clinical profile of anti-AMPA receptor encephalitis. Neurology 2010, 74:857-859.
123. Gross G., Huber G. Somatically based psychoses and the problem of symptomatic schizophrenia. Neurol Psychiatry Brain Res 2007, 14:131-142.
124. Gupta S., Soellinger M., Boesiger P., Poulikakos D., Kurtcuoglu V. Three-dimensional computational modeling of subject-specific cerebrospinal fluid flow in the subarachnoid space. J Biomech Eng 2009, 131:021010.
125. Gupta S., Soellinger M., Grzybowski D.M., Boesiger P., Biddiscombe J., Poulikakos D., et al. Cerebrospinal fluid dynamics in the human cranial subarachnoid space: an overlooked mediator of cerebral disease. I. Computational model. J R Soc Interface 2010, 7:1195-1204.
126. Hanson D.R., Gottesman I.I. Theories of schizophrenia: a genetic-inflammatory-vascular synthesis. BMC Med Genet 2005, 6:7.
127. Harrison P.J., GRoberts G.W. The neuropathology of schizophrenia - progress and interpretation 2000, Oxford University Press Inc., New York.
128. Hellweg R., von Richthofen S., Anders D., Baethge C., Ropke S., Hartung H.D., et al. The time course of nerve growth factor content in different neuropsychiatric diseases - a unifying hypothesis. J Neural Transm 1998, 105:871-903.
129. Herden C., Herzog S., Richt J.A., Nesseler A., Christ M., Failing K., et al. Distribution of Borna disease virus in the brain of rats infected with an obesity-inducing virus strain. Brain Pathol 2000, 10:39-48.
130. Herden C., Schluesener H.J., Richt J.A. Expression of allograft inflammatory factor-1 and haeme oxygenase-1 in brains of rats infected with the neurotropic Borna disease virus. Neuropathol Appl Neurobiol 2005, 31:512-521.
131. Herrington J.D., Schultz R.T. Neuroimaging of autism spectrum disorders. Understanding neuropsychiatric disorders - insights from neuroimaging 2011, 517. Cambridge University Press, New York. M.E. Shenton, B.I. Turetsky (Eds.).
132. Herzog S., Rott R. Replication of Borna disease virus in cell cultures. Med Microbiol Immunol 1980, 168:153-158.
133. Herzog S., Frese K., Rott R. Studies on the genetic control of resistance of black hooded rats to Borna disease. J Gen Virol 1991, 72(Pt 3):535-540.
134. Herzog S., Pfeuffer I., Haberzettl K., Feldmann H., Frese K., Bechter K., et al. Molecular characterization of Borna disease virus from naturally infected animals and possible links to human disorders. Arch Virol Suppl 1997, 13:183-190.
135. Herzog S., Herden C., Frese K., Lange-Herbst H., Grabner A. Diagnostik der BDV-Infektion beim Pferd: Widersprüche zwischen Intra-vitam- und Post-mortem-Untersuchungen. Pferdeheilkunde 2008, 24:766-774.
136. Heuser M., Thomann P.A., Essig M., Bachmann S., Schroder J. Neurological signs and morphological cerebral changes in schizophrenia: an analysis of NSS subscales in patients with first episode psychosis. Psychiatry Res 2011, 192:69-76.
137. Hobbs J.A. Detection of adeno-associated virus 2 and parvovirus B19 in the human dorsolateral prefrontal cortex. J Neurovirol 2006, 12:190-199.
138. Holmes E., Tsang T.M., Huang J.T., Leweke F.M., Koethe D., Gerth C.W., et al. Metabolic profiling of CSF: evidence that early intervention may impact on disease progression and outcome in schizophrenia. PLoS Med 2006, 3:e327.
139. Holtzheimer P.E., Mayberg H.S. Neuroimaging of mood disorders: commentary. Understanding neuropsychiatric disorders - insights from neuroimaging 2011, 197. Cambridge University Press, New York. M.E. Shenton, B.I. Turetsky (Eds.).
140. Horie M., Honda T., Suzuki Y., Kobayashi Y., Daito T., Oshida T., et al. Endogenous non-retroviral RNA virus elements in mammalian genomes. Nature 2010, 463:84-87.
141. Hornig M., Briese T., Licinio J., Khabbaz R.F., Altshuler L.L., Potkin S.G., et al. Absence of evidence for bornavirus infection in schizophrenia, bipolar disorder and major depressive disorder. Mol Psychiatry 2012, 17(5):486-493.
142. Houtchens M.K., Benedict R.H., Killiany R., Sharma J., Jaisani Z., Singh B., et al. Thalamic atrophy and cognition in multiple sclerosis. Neurology 2007, 69:1213-1223.
143. Huang J.T., Leweke F.M., Oxley D., Wang L., Harris N., Koethe D., et al. Disease biomarkers in cerebrospinal fluid of patients with first-onset psychosis. PLoS Med 2006, 3:e428.
144. Huang J.T., Leweke F.M., Tsang T.M., Koethe D., Kranaster L., Gerth C.W., et al. CSF metabolic and proteomic profiles in patients prodromal for psychosis. PLoS One 2007, 2:e756.
145. Huber G., Gross G., Schuttler R. Schizophrenia. Clinical course and social psychiatric long term examinations of schizophrenic patients hospitalized in Bonn from 1945-1959. Monogr Gesamtgeb Psychiatr Psychiatry Ser 1979, 21:1-399.
146. Insel T.R. Rethinking schizophrenia. Nature 2010, 468:187-193.
147. Irani S.R., Vincent A. Autoimmune encephalitis - new awareness, challenging questions. Discov Med 2011, 11:449-458.
148. Irani S.R., Bera K., Waters P., Zuliani L., Maxwell S., Zandi M.S., et al. N-methyl-d-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes. Brain 2010, 133:1655-1667.
149. Jefferies C., Wynne C., Higgs R. Antiviral TRIMs: friend or foe in autoimmune and autoinflammatory disease?. Nat Rev Immunol 2011, 11:617-625.
150. Kaminski M., Bechmann I., et al. Migration of monocytes after intracerebral injection at entorhinal cortex lesion site. J Leukoc Biol 2012.
151. Kamitani W., Ono E., Yoshino S., Kobayashi T., Taharaguchi S., Lee B.J., et al. Glial expression of Borna disease virus phosphoprotein induces behavioral and neurological abnormalities in transgenic mice. Proc Natl Acad Sci U S A 2003, 100:8969-8974.
152. Kang H.J., Kawasawa Y.I., Cheng F., Zhu Y., Xu X., Li M., et al. Spatio-temporal transcriptome of the human brain. Nature 2011, 478:483-489.
153. Keizman D., Rogowski O., et al. Low-grade systemic inflammation in patients with amyotrophic lateral sclerosis. Acta Neurol Scand 2009, 119(6):383-389.
154. Kerschensteiner M., Meinl E., Hohlfeld R. Neuro-immune crosstalk in CNS diseases. Neuroscience 2009, 158:1122-1132.
155. Kirkbride J.B., Scoriels L. Review of the 6th symposium for the search for the causes of schizophrenia, Sao Paulo, Brazil, 3-6 February 2009. Eur Arch Psychiatry Clin Neurosci 2009, 259:505-509.
156. Kleines M., Schiefer J., Stienen A., Blaum M., Ritter K., Hausler M. Expanding the spectrum of neurological disease associated with Epstein-Barr virus activity. Eur J Clin Microbiol Infect Dis 2011, 30:1561-1569.
157. Klosterkötter J. Early detection of schizophrenia. Neurol Psychiatry Brain Res 2011, 17:1-10.
158. Klosterkotter J., Gross G., Huber G. The concept of process activity in idiopathic psychoses. Nervenarzt 1989, 60:740-744.
159. Kochunov P., Glahn D.C., Nichols T.E., Winkler A.M., Hong E.L., Holcomb H.H., et al. Genetic analysis of cortical thickness and fractional anisotropy of water diffusion in the brain. Front Neurosci 2011, 5:120.
160. Koponen H., Rantakallio P., Veijola J., Jones P., Jokelainen J., Isohanni M. Childhood central nervous system infections and risk for schizophrenia. Eur Arch Psychiatry Clin Neurosci 2004, 254:9-13.
161. Koster-Patzlaff C., Hosseini S.M., Reuss B. Persistent Borna disease virus infection changes expression and function of astroglial gap junctions in vivo and in vitro. Brain Res 2007, 1184:316-332.
162. Kreutzberg G.W. Microglia: a sensor for pathological events in the CNS. Trends Neurosci 1996, 19:312-318.
163. Krishnamoorthy G., Saxena A., Mars L.T., Domingues H.S., Mentele R., Ben-Nun A., et al. Myelin-specific T cells also recognize neuronal autoantigen in a transgenic mouse model of multiple sclerosis. Nat Med 2009, 15:626-632.
164. Kurian M.A., Gissen P., Smith M., Heales S., Clayton P.T. The monoamine neurotransmitter disorders: an expanding range of neurological syndromes. Lancet Neurol 2011, 10:721-733.
165. Lang U.E., Jockers-Scherubl M.C., Hellweg R. State of the art of the neurotrophin hypothesis in psychiatric disorders: implications and limitations. J Neural Transm 2004, 111:387-411.
166. Lawn S.D., Zumla A.I. Tuberculosis. Lancet 2011, 378:57-72.
167. Leboyer M., Tamouza R., Charron D., Faucard R., Perron H. Human endogenous retrovirus type W (HERV-W) in schizophrenia: a new avenue of research at the gene-environment interface. World J Biol Psychiatry 2011.
168. Lederbogen F., Kirsch P., Haddad L., Streit F., Tost H., Schuch P., et al. City living and urban upbringing affect neural social stress processing in humans. Nature 2011, 474:498-501.
169. Lehtinen M.K., Zappaterra M.W., Chen X., Yang Y.J., Hill A.D., Lun M., et al. The cerebrospinal fluid provides a proliferative niche for neural progenitor cells. Neuron 2011, 69:893-905.
170. Lencer R., Keedy S.K., Reilly J.L., McDonough B.E., Harris M.S., Sprenger A., et al. Altered transfer of visual motion information to parietal association cortex in untreated first-episode psychosis: implications for pursuit eye tracking. Psychiatry Res 2011, 194:30-38.
171. Lennox B.R., Coles A.J., Vincent A. Antibody-mediated encephalitis: a treatable cause of schizophrenia. Br J Psychiatry 2012, 200:92-94.
172. Leweke F.M., Gerth C.W., Koethe D., Klosterkotter J., Ruslanova I., Krivogorsky B., et al. Antibodies to infectious agents in individuals with recent onset schizophrenia. Eur Arch Psychiatry Clin Neurosci 2004, 254:4-8.
173. Li F., Nellaker C., Yolken R.H., Karlsson H. A systematic evaluation of expression of HERV-W elements; influence of genomic context, viral structure and orientation. BMC Genomics 2011, 12:22.
174. Licinio J. Potential diagnostic markers for postpartum depression point out to altered immune signaling. Mol Psychiatry 2010, 15:1.
175. Licinio J., Wong M.L. The role of inflammatory mediators in the biology of major depression: central nervous system cytokines modulate the biological substrate of depressive symptoms, regulate stress-responsive systems, and contribute to neurotoxicity and neuroprotection. Mol Psychiatry 1999, 4:317-327.
176. Lieb K., Hufert F.T., Bechter K., Bauer J., Kornhuber J. Depression, Borna disease, and amantadine. Lancet 1997, 349:958.
177. Lipkin W.I., Briese T., Hornig M. Borna disease virus - fact and fantasy. Virus Res 2011, 162:162-172.
178. Locatelli G., Wortge S., Buch T., Ingold B., Frommer F., Sobottka B., et al. Primary oligodendrocyte death does not elicit anti-CNS immunity. Nat Neurosci 2012, 15(4):543-550.
179. Lucchinetti C.F., Popescu B.F., Bunyan R.F., Moll N.M., Roemer S.F., Lassmann H., et al. Inflammatory cortical demyelination in early multiple sclerosis. N Engl J Med 2011, 365:2188-2197.
180. Lynch M.A., Mills K.H. Immunology meets neuroscience - opportunities for immune intervention in neurodegenerative diseases. Brain Behav Immun 2012, 26(1):1-10.
181. MacKenzie-Graham A., Tinsley M.R., Shah K.P., Aguilar C., Strickland L.V., Boline J., et al. Cerebellar cortical atrophy in experimental autoimmune encephalomyelitis. Neuroimage 2006, 32:1016-1023.
182. Maes M. Cytokines in schizophrenia. Biol Psychiatry 1997, 42:308-309.
183. Marques F., Sousa J.C., Coppola G., Geschwind D.H., Sousa N., Palha J.A., et al. The choroid plexus response to a repeated peripheral inflammatory stimulus. BMC Neurosci 2009, 10:135.
184. Marshall B.J. Campylobacter pylori: its link to gastritis and peptic ulcer disease. Rev Infect Dis 1990, 12(Suppl. 1):S87-S93.
185. Martins-de-Souza D., Lebar M., Turck C.W. Proteome analyses of cultured astrocytes treated with MK-801 and clozapine: similarities with schizophrenia. Eur Arch Psychiatry Clin Neurosci 2011, 261:217-228.
186. Matzinger P., Kamala T. Tissue-based class control: the other side of tolerance. Nat Rev Immunol 2011, 11:221-230.
187. Maxeiner H.G., Rojewski M.T., Schmitt A., Tumani H., Bechter K., Schmitt M. Flow cytometric analysis of T cell subsets in paired samples of cerebrospinal fluid and peripheral blood from patients with neurological and psychiatric disorders. Brain Behav Immun 2009, 23:134-142.
188. McGeer P.L., McGeer E.G. The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases. Brain Res Brain Res Rev 1995, 21:195-218.
189. McLeod J.G., Hammond S.R., Kurtzke J.F. Migration and multiple sclerosis in immigrants to Australia from United Kingdom and Ireland: a reassessment. I. Risk of MS by age at immigration. J Neurol 2011, 258:1140-1149.
190. Medzhitov R. Origin and physiological roles of inflammation. Nature 2008, 454:428-435.
191. Meinl E., Krumbholz M., Hohlfeld R. B lineage cells in the inflammatory central nervous system environment: migration, maintenance, local antibody production, and therapeutic modulation. Ann Neurol 2006, 59:880-892.
192. Meltzer H.Y., Crayton J.W. Subterminal motor nerve abnormalities in psychotic patients. Nature 1974, 249:373-375.
193. Menninger K.A. Influenza and schizophrenia. An analysis of post-influenzal "dementia precox," as of 1918, and five years later further studies of the psychiatric aspects of influenza. 1926. Am J Psychiatry 1994, 151:182-187.
194. Meyer U. Anti-inflammatory signaling in schizophrenia. Brain Behav Immun 2011, 25(8):1507-1518.
195. Meyer U., Nyffeler M., Engler A., Urwyler A., Schedlowski M., Knuesel I., et al. The time of prenatal immune challenge determines the specificity of inflammation-mediated brain and behavioral pathology. J Neurosci 2006, 26:4752-4762.
196. Meyer J.M., McEvoy J.P., Davis V.G., Goff D.C., Nasrallah H.A., Davis S.M., et al. Inflammatory markers in schizophrenia: comparing antipsychotic effects in phase 1 of the clinical antipsychotic trials of intervention effectiveness study. Biol Psychiatry 2009, 66:1013-1022.
197. Miller J., Drost D.J., Jensen E., Manchanda R., Northcott S., Neufeld R.W., et al. Progressive membrane phospholipid changes in first episode schizophrenia with high field magnetic resonance spectroscopy. Psychiatry Res 2012, 201:25-33.
198. Mills K.H. TLR-dependent T cell activation in autoimmunity. Nat Rev Immunol 2011, 11:807-822.
199. Minshew N.J. Neuroimaging of developmental: commentary. Understanding neuropsychiatric disorders - insights from neuroimaging 2011, 555. Cambridge University Press, New York. M.E. Shenton, B.I. Turetsky (Eds.).
200. Mulert C., Kirsch V., Pascual-Marqui R., McCarley R.W., Spencer K.M. Long-range synchrony of gamma oscillations and auditory hallucination symptoms in schizophrenia. Int J Psychophysiol 2011, 79:55-63.
201. Mulert C., Kirsch V., Whitford T.J., Alvarado J., Pelavin P., McCarley R.W., et al. Hearing voices: a role of interhemispheric auditory connectivity?. World J Biol Psychiatry 2011.
202. Muller N., Schwarz M.J. Immune system and schizophrenia. Curr Immunol Rev 2010, 6:213-220.
203. Musgrave T., Benson C., Wong G., Browne I., Tenorio G., Rauw G., et al. The MAO inhibitor phenelzine improves functional outcomes in mice with experimental autoimmune encephalomyelitis (EAE). Brain Behav Immun 2011, 25:1677-1688.
204. Mutnal M.B., Hu S., Little M.R., Lokensgard J.R. Memory T cells persisting in the brain following MCMV infection induce long-term microglial activation via interferon-gamma. J Neurovirol 2011, 17:424-437.
205. Myint A.M., Kim Y.K. Cytokine-serotonin interaction through IDO: a neurodegeneration hypothesis of depression. Med Hypotheses 2003, 61:519-525.
206. Myint A.M., Schwarz M.J., Verkerk R., Mueller H.H., Zach J., Scharpe S., et al. Reversal of imbalance between kynurenic acid and 3-hydroxykynurenine by antipsychotics in medication-naive and medication-free schizophrenic patients. Brain Behav Immun 2011, 25(8):1576-1581.
207. Najmabadi H., Hu H., Garshasbi M., Zemojtel T., Abedini S.S., Chen W., et al. Deep sequencing reveals 50 novel genes for recessive cognitive disorders. Nature 2011, 478:57-63.
208. Nathan C. Points of control in inflammation. Nature 2002, 420(6917):846-852.
209. Nave K.A. Myelination and support of axonal integrity by glia. Nature 2010, 468:244-252.
210. Niebuhr D.W., Millikan A.M., Cowan D.N., Yolken R., Li Y., Weber N.S. Selected infectious agents and risk of schizophrenia among U.S. military personnel. Am J Psychiatry 2008, 165:99-106.
211. Nielsen P.R., Laursen T.M., Mortensen P.B. Association between parental hospital-treated infection and the risk of schizophrenia in adolescence and early adulthood. Schizophr Bull 2011.
212. Nieratschker V., Nothen M.M., Rietschel M. New genetic findings in schizophrenia: is there still room for the dopamine hypothesis of schizophrenia?. Front Behav Neurosci 2010, 4:23.
213. Nikisch G., Baumann P., Liu T., Mathe A.A. Quetiapine affects neuropeptide Y and corticotropin-releasing hormone in cerebrospinal fluid from schizophrenia patients: relationship to depression and anxiety symptoms and to treatment response. Int J Neuropsychopharmacol 2011, 1-11.
214. Nord M., Farde L. Antipsychotic occupancy of dopamine receptors in schizophrenia. CNS Neurosci Ther 2011, 17:97-103.
215. O'Callaghan J.P., Sriram K., Miller D.B. Defining "neuroinflammation". Ann N Y Acad Sci 2008, 1139:318-330.
216. O'Connor S.M., Taylor C.E., Hughes J.M. Emerging infectious determinants of chronic diseases. Emerg Infect Dis 2006, 12:1051-1057.
217. Oldstone M.B. Molecular anatomy of viral disease. The George Cotzias memorial lecture 1986. Neurology 1987, 37:453-460.
218. Oldstone M.B.A. Viruses can cause disease in the absence of morphologic evidence of cell injury: pathology in the absence of cell lysis - implication for pathologist's future study of disease. Neuropathology 1990, 123-129. Williams, New York. P.A. Cancilla, F. Vogel (Eds.).
219. Oleszak E.L., Chang J.R., Friedman H., Katsetos C.D., Platsoucas C.D. Theiler's virus infection: a model for multiple sclerosis. Clin Microbiol Rev 2004, 17:174-207.
220. Oleszak E.L., Zhang X., Lin W.L., Lu S., Chang J.R., Tsygankov A., et al. Immunopathology of multiple sclerosis and psychoses. In Vivo 2007, 21:945.
221. Osborn A.G., Salzman K.L., Barkovich A.J. Diagnostic imaging: brain 2010, Lippincott Williams & Wilkins.
222. Ovanesov M.V., Ayhan Y., Wolbert C., Moldovan K., Sauder C., Pletnikov M.V. Astrocytes play a key role in activation of microglia by persistent Borna disease virus infection. J Neuroinflammation 2008, 5. art. no. 50.
223. Owen M.J., O'Donovan M.C., Thapar A., Craddock N. Neurodevelopmental hypothesis of schizophrenia. Br J Psychiatry 2011, 198:173-175.
224. Pantelis C., Velakoulis D., Wood S.J., Yucel M., Yung A.R., Phillips L.J., et al. Neuroimaging and emerging psychotic disorders: the Melbourne ultra-high risk studies. Int Rev Psychiatry 2007, 19:371-381.
225. Peerbooms O.L., van Os J., Drukker M., Kenis G., Hoogveld L., de Hert M., et al. Meta-analysis of MTHFR gene variants in schizophrenia, bipolar disorder and unipolar depressive disorder: evidence for a common genetic vulnerability?. Brain Behav Immun 2011, 25:1530-1543.
226. Perron H., Lang A. The human endogenous retrovirus link between genes and environment in multiple sclerosis and in multifactorial diseases associating neuroinflammation. Clin Rev Allergy Immunol 2010, 39:51-61.
227. Perron H., Mekaoui L., Bernard C., Veas F., Stefas I., Leboyer M. Endogenous retrovirus type W GAG and envelope protein antigenemia in serum of schizophrenic patients. Biol Psychiatry 2008, 64:1019-1023.
228. Picard D., Janela B., Descamps V., D'Incan M., Courville P., Jacquot S., et al. Drug reaction with eosinophilia and systemic symptoms (DRESS): a multiorgan antiviral T cell response. Sci Transl Med 2010, 2:46ra62.
229. Piontkewitz Y., Assaf Y., Weiner I. Clozapine administration in adolescence prevents postpubertal emergence of brain structural pathology in an animal model of schizophrenia. Biol Psychiatry 2009, 66:1038-1046.
230. Planz O., Bechter K., Schwemmle M. Human Borna disease virus infection. Borna disease virus - role in neurobehavioral disease 2002, 179-225. ASM Press, Washington. K. Carbone (Ed.).
231. Pletnikov M., Gonzalez-Dunia D., Stitz L. Experimental infection: pathogenesis of neurobehavioral disease. Borna disease virus and its role in neurobehavioral disease 2002, 125-178. ASM Press, Washington, DC. K. Carbone (Ed.).
232. Pletnikov M.V., Ayhan Y., Nikolskaia O., Xu Y., Ovanesov M.V., Huang H., et al. Inducible expression of mutant human DISC1 in mice is associated with brain and behavioral abnormalities reminiscent of schizophrenia. Mol Psychiatry 2008, 13(173-86):115.
233. Prandovszky E., Gaskell E., Martin H., Dubey J.P., Webster J.P., McConkey G.A. The neurotropic parasite Toxoplasma gondii increases dopamine metabolism. PLoS One 2011, 6:e23866.
234. Prasad K.M., Shirts B.H., Yolken R.H., Keshavan M.S., Nimgaonkar V.L. Brain morphological changes associated with exposure to HSV1 in first-episode schizophrenia. Mol Psychiatry 2007, 12(105-13):1.
235. Prasad K.M., Eack S.M., Goradia D., Pancholi K.M., Keshavan M.S., Yolken R.H., et al. Progressive gray matter loss and changes in cognitive functioning associated with exposure to herpes simplex virus 1 in schizophrenia: a longitudinal study. Am J Psychiatry 2011, 168:822-830.
236. Pruss H., Dalmau J., Harms L., Holtje M., Ahnert-Hilger G., Borowski K., et al. Retrospective analysis of NMDA receptor antibodies in encephalitis of unknown origin. Neurology 2010, 75:1735-1739.
237. Pugliese A., Beltramo T., Torre D., Roccatello D. Parvovirus B19 and immune disorders. Cell Biochem Funct 2007, 25:639-641.
238. Raivich G., Jones L.L., Werner A., Bluthmann H., Doetschmann T., Kreutzberg G.W. Molecular signals for glial activation: pro- and anti-inflammatory cytokines in the injured brain. Acta Neurochir Suppl 1999, 73:21-30.
239. Ransohoff R.M. Immunology: in the beginning. Nature 2009, 462:41-42.
240. Redzic Z. Molecular biology of the blood-brain and the blood-cerebrospinal fluid barriers: similarities and differences. Fluids Barriers CNS 2011, 8(1):3.
241. Reiber H., Peter J.B. Cerebrospinal fluid analysis: disease-related data patterns and evaluation programs. J Neurol Sci 2001, 184:101-122.
242. Ribbe K., Ackermann V., Schwitulla J., Begemann M., Papiol S., Grube S., et al. Prediction of the risk of comorbid alcoholism in schizophrenia by interaction of common genetic variants in the corticotropin-releasing factor system. Arch Gen Psychiatry 2011, 68:1247-1256.
243. Richt J.A., Alexander R.C., Herzog S., Hooper D.C., Kean R., Spitsin S., et al. Failure to detect Borna disease virus infection in peripheral blood leukocytes from humans with psychiatric disorders. J Neurovirol 1997, 3:174-178.
244. Richt J.A., Pfeuffer I., Christ M., Frese K., Bechter K., Herzog S. Borna disease virus infection in animals and humans. Emerg Infect Dis 1997, 3:343-352.
245. Riecher-Rossler A., Pflueger M.O., Aston J., Borgwardt S.J., Brewer W.J., Gschwandtner U., et al. Efficacy of using cognitive status in predicting psychosis: a 7-year follow-up. Biol Psychiatry 2009, 66:1023-1030.
246. Rioux J.D., Abbas A.K. Paths to understanding the genetic basis of autoimmune disease. Nature 2005, 435:584-589.
247. Rocca M.A., Mondria T., Valsasina P., Sormani M.P., Flach Z.H., Te Boekhorst P.A., et al. A three-year study of brain atrophy after autologous hematopoietic stem cell transplantation in rapidly evolving secondary progressive multiple sclerosis. AJNR Am J Neuroradiol 2007, 28:1659-1661.
248. Rolls E.T., Loh M., Deco G., Winterer G. Computational models of schizophrenia and dopamine modulation in the prefrontal cortex. Nat Rev Neurosci 2008, 9:696-709.
249. Rott R., Herzog S., Bechter K., Frese K. Borna disease, a possible hazard for man?. Arch Virol 1991, 118:143-149.
250. Rott O., Herzog S., Cash E. T cell memory specific for self and non-self antigens in rats persistently infected with Borna disease virus. Clin Exp Immunol 1993, 93:370-376.
251. Rujescu D. Are we going to end up with many distinct genomic syndromes in psychiatry?. Eur Arch Psychiatry Clin Neurosci 2011, 261:145-146.
252. Saijo K., Glass C.K. Microglial cell origin and phenotypes in health and disease. Nat Rev Immunol 2011, 11:775-787.
253. Santos A., Meyer-Lindenberg A. Neuroimaging of Williams-Beuren syndrome. Understanding neuropsychiatric disorders - insights from neuroimaging 2011, 537. Cambridge University Press, New York. M.E. Shenton, B.I. Turetsky (Eds.).
254. Sawcer S., Hellenthal G., Pirinen M., Spencer C.C., Patsopoulos N.A., Moutsianas L., et al. Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature 2011, 476:214-219.
255. Saxton K.B., John-Henderson N., Reid M.W., Francis D.D. The social environment and IL-6 in rats and humans. Brain Behav Immun 2011, 25:1617-1625.
256. Schmitt A., Hasan A., Gruber O., Falkai P. Schizophrenia as a disorder of disconnectivity. Eur Arch Psychiatry Clin Neurosci 2011, 261(Suppl. 2):150-154.
257. Schmitt M., Neubauer A., Greiner J., Xu X., Barth T.F., Bechter K. Spreading of acute myeloid leukemia cells by trafficking along the peripheral outflow pathway of cerebrospinal fluid. Anticancer Res 2011, 31:2343-2345.
258. Schwartz M., Kipnis J. A conceptual revolution in the relationships between the brain and immunity. Brain Behav Immun 2011, 25:817-819.
259. Schwartz M., Shechter R. Protective autoimmunity functions by intracranial immunosurveillance to support the mind: the missing link between health and disease. Mol Psychiatry 2010, 15:342-354.
260. Schwarz E., Guest P.C., Rahmoune H., Harris L.W., Wang L., Leweke F.M., et al. Identification of a biological signature for schizophrenia in serum. Mol Psychiatry 2012, 17(5):494-502.
261. Schwemmle M. Borna disease virus infection in psychiatric patients: are we on the right track?. Lancet Infect Dis 2001, 1:46-52.
262. Schwemmle M., Heimrich B. Viral interference with neuronal integrity: what can we learn from the Borna disease virus?. Cell Tissue Res 2011, 344:13-16.
263. Schwemmle M., Jehle C., Formella S., Staeheli P. Sequence similarities between human bornavirus isolates and laboratory strains question human origin. Lancet 1999, 354:1973-1974.
264. Shenton M.E., Turetsky B.I. Understanding neuropsychiatric disorders - insights from neuroimaging 2011, Cambridge University Press, New York.
265. Simon A.E., Velthorst E., Nieman D.H., Linszen D., Umbricht D., de Haan L. Ultra high-risk state for psychosis and non-transition: a systematic review. Schizophr Res 2011, 132(1):8-17.
266. Skulina C., Schmidt S., Dornmair K., Babbe H., Roers A., Rajewsky K., et al. Multiple sclerosis: brain-infiltrating CD8+ T cells persist as clonal expansions in the cerebrospinal fluid and blood. Proc Natl Acad Sci U S A 2004, 101:2428-2433.
267. Smiley J.F., Rosoklija G., Mancevski B., Pergolizzi D., Figarsky K., Bleiwas C., et al. Hemispheric comparisons of neuron density in the planum temporale of schizophrenia and nonpsychiatric brains. Psychiatry Res 2011, 192:1-11.
268. Sprankel H., Richarz K., Ludwig H., Rott R. Behavior alterations in tree shrews (Tupaia glis, Diard 1820) induced by Borna disease virus. Med Microbiol Immunol 1978, 165:1-18.
269. St Clair D., Xu M., Wang P., Yu Y., Fang Y., Zhang F., et al. Rates of adult schizophrenia following prenatal exposure to the Chinese famine of 1959-1961. JAMA 2005, 294:557-562.
270. Stanek G., Wormser G.P., Gray J., Strle F. Lyme borreliosis. Lancet 2012, 379(9814):461-473.
271. Stanta J.L., Saldova R., Struwe W.B., Byrne J.C., Leweke F.M., Rothermund M., et al. Identification of N-glycosylation changes in the CSF and serum in patients with schizophrenia. J Proteome Res 2010, 9:4476-4489.
272. Stefansson H., Ophoff R.A., Steinberg S., Andreassen O.A., Cichon S., Rujescu D., et al. Common variants conferring risk of schizophrenia. Nature 2009, 460:744-747.
273. Steiner J., Bielau H., Brisch R., Danos P., Ullrich O., Mawrin C., et al. Immunological aspects in the neurobiology of suicide: elevated microglial density in schizophrenia and depression is associated with suicide. J Psychiatr Res 2008, 42:151-157.
274. Steiner J., Bogerts B., Sarnyai Z., Walter M., Gos T., Bernstein H.G., et al. Bridging the gap between the immune and glutamate hypotheses of schizophrenia and major depression: potential role of glial NMDA receptor modulators and impaired blood-brain barrier integrity. World J Biol Psychiatry 2011.
275. Strik C., Klose U., Erb M., Strik H., Grodd W. Intracranial oscillations of cerebrospinal fluid and blood flows: analysis with magnetic resonance imaging. J Magn Reson Imaging 2002, 15:251-258.
276. Sun D., Stuart G.W., Jenkinson M., Wood S.J., McGorry P.D., Velakoulis D., et al. Brain surface contraction mapped in first-episode schizophrenia: a longitudinal magnetic resonance imaging study. Mol Psychiatry 2009, 14:976-986.
277. Susser E.S., Lin S.P. Schizophrenia after prenatal exposure to the Dutch Hunger Winter of 1944-1945. Arch Gen Psychiatry 1992, 49:983-988.
278. Tekok-Kilic A., Benedict R.H., Weinstock-Guttman B., Dwyer M.G., Carone D., Srinivasaraghavan B., et al. Independent contributions of cortical gray matter atrophy and ventricle enlargement for predicting neuropsychological impairment in multiple sclerosis. Neuroimage 2007, 36:1294-1300.
279. Tlaskalova-Hogenova H., Stepankova R., Kozakova H., Hudcovic T., Vannucci L., Tuckova L., et al. The role of gut microbiota (commensal bacteria) and the mucosal barrier in the pathogenesis of inflammatory and autoimmune diseases and cancer: contribution of germ-free and gnotobiotic animal models of human diseases. Cell Mol Immunol 2011, 8:110-120.
280. Trushina E., McMurray C.T. Oxidative stress and mitochondrial dysfunction in neurodegenerative diseases. Neuroscience 2007, 145:1233-1248.
281. Uher R. The role of genetic variation in the causation of mental illness: an evolution-informed framework. Mol Psychiatry 2009, 14(12):1072-1082.
282. Urbach H., Soeder B.M., Jeub M., Klockgether T., Meyer B., Bien C.G. Serial MRI of limbic encephalitis. Neuroradiology 2006, 48:380-386.
283. van Haren N.E., Schnack H.G., Cahn W., Van Den Heuvel M.P., Lepage C., Collins L., et al. Changes in cortical thickness during the course of illness in schizophrenia. Arch Gen Psychiatry 2011, 68:871-880.
284. van Os J., Kenis G., Rutten B.P. The environment and schizophrenia. Nature 2010, 468:203-212.
285. Verrall L., Burnet P.W., Betts J.F., Harrison P.J. The neurobiology of d-amino acid oxidase and its involvement in schizophrenia. Mol Psychiatry 2010, 15:122-137.
286. Vincent A., Buckley C., Schott J.M., Baker I., Dewar B.K., Detert N., et al. Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis. Brain 2004, 127:701-712.
287. Vincent A., Bien C.G., Irani S.R., Waters P. Autoantibodies associated with diseases of the CNS: new developments and future challenges. Lancet Neurol 2011, 10:759-772.
288. Voineagu I., Wang X., Johnston P., Lowe J.K., Tian Y., Horvath S., et al. Transcriptomic analysis of autistic brain reveals convergent molecular pathology. Nature 2011, 474:380-384.
289. Wallin M.T., Page W.F., Kurtzke J.F. Migration and multiple sclerosis in Alaskan military veterans. J Neurol 2009, 256:1413-1417.
290. Wang H., Yolken R.H., Hoekstra P.J., Burger H., Klein H.C. Antibodies to infectious agents and the positive symptom dimension of subclinical psychosis: the TRAILS study. Schizophr Res 2011, 129:47-51.
291. Werner-Keiss N., Garten W., Richt J.A., Porombka D., Algermissen D., Herzog S., et al. Restricted expression of Borna disease virus glycoprotein in brains of experimentally infected Lewis rats. Neuropathol Appl Neurobiol 2008, 34:590-602.
292. Westergaard T., Mortensen P.B., Pedersen C.B., Wohlfahrt J., Melbye M. Exposure to prenatal and childhood infections and the risk of schizophrenia: suggestions from a study of sibship characteristics and influenza prevalence. Arch Gen Psychiatry 1999, 56:993-998.
293. White T., Andreasen N.C., Nopoulos P., Magnotta V. Gyrification abnormalities in childhood- and adolescent-onset schizophrenia. Biol Psychiatry 2003, 54:418-426.
294. White T., Schmidt M., Karatekin C. White matter 'potholes' in early-onset schizophrenia: a new approach to evaluate white matter microstructure using diffusion tensor imaging. Psychiatry Res 2009, 174:110-115.
295. White T., Su S., Schmidt M., Kao C.Y., Sapiro G. The development of gyrification in childhood and adolescence. Brain Cogn 2010, 72:36-45.
296. White T., Moeller S., Schmidt M., Pardo J.V., Olman C. Evidence for intact local connectivity but disrupted regional function in the occipital lobe in children and adolescents with schizophrenia. Hum Brain Mapp 2011.
297. White T., Schmidt M., Kim D.I., Calhoun V.D. Disrupted functional brain connectivity during verbal working memory in children and adolescents with schizophrenia. Cereb Cortex 2011, 21:510-518.
298. Whitford T.J., Shenton M.E. Structural imaging of schizophrenia. Understanding neuropsychiatric disorders 2011, 1-29. Cambridge University Press, New York. M.E. Shenton, B.I. Turetsky (Eds.).
299. Wildemann B., Oschmann P., Reiber H. Laboratory diagnosis in neurology 2010, Thieme, Stuttgart.
300. Willyard C. Gut reaction. Nature 2011, 479:S5-S7.
301. Wilson E.H., Harris T.H., Mrass P., John B., Tait E.D., Wu G.F., et al. Behavior of parasite-specific effector CD8+ T cells in the brain and visualization of a kinesis-associated system of reticular fibers. Immunity 2009, 30:300-311.
302. Wolburg H., Paulus W. Choroid plexus: biology and pathology. Acta Neuropathol 2010, 119:75-88.
303. Wollinsky K.H., Hulser P.J., Brinkmeier H., Aulkemeyer P., Bossenecker W., Huber-Hartmann K.H., et al. CSF filtration is an effective treatment of Guillain-Barre syndrome: a randomized clinical trial. Neurology 2001, 57:774-780.
304. Wood F., Bloor M.J. Borna disease virus: the generation and review of a scientific study. Soc Sci Med 2006, 63:1072-1083.
305. Yolken R.H., Torrey E.F. Are some cases of psychosis caused by microbial agents? A review of the evidence. Mol Psychiatry 2008, 13:470-479.
306. Yolken R.H., Torrey E.F., Lieberman J.A., Yang S., Dickerson F.B. Serological evidence of exposure to herpes simplex virus type 1 is associated with cognitive deficits in the CATIE schizophrenia sample. Schizophr Res 2011, 128:61-65.
307. Zandi M.S., Irani S.R., Lang B., Waters P., Jones P.B., McKenna P., et al. Disease-relevant autoantibodies in first episode schizophrenia. J Neurol 2011, 258:686-688.
308. Zur Hausen H. Cervical carcinoma and human papillomavirus: on the road to preventing a major human cancer. J Natl Cancer Inst 2001, 93:252-253.